EZH2: an epigenetic gatekeeper promoting lymphomagenesis
- PMID: 23680141
- DOI: 10.1016/j.ccr.2013.04.028
EZH2: an epigenetic gatekeeper promoting lymphomagenesis
Abstract
In this issue of Cancer Cell, Béguelin and colleagues highlight EZH2 as an essential regulator for B cell activation and report an addiction of germinal center-derived neoplasms to EZH2 activity. This reversible process is specifically targetable and hence presents high translational value for lymphoma therapy.
Copyright © 2013 Elsevier Inc. All rights reserved.
Comment on
-
EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation.Cancer Cell. 2013 May 13;23(5):677-92. doi: 10.1016/j.ccr.2013.04.011. Cancer Cell. 2013. PMID: 23680150 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
